Kallyope

Kallyope company information, Employees & Contact Information

Explore related pages

Related company profiles:

At Kallyope, we focus on big health challenges that matter to patients and families. We aim to discover and develop effective, easy to use, and well-tolerated oral agents addressing metabolic, neurological, and gastrointestinal diseases. Inside every human body is a complex, unexplored network of metabolic, neurological, and gastrointestinal interconnections. Our scientists are unlocking the mysteries of this network to develop oral therapies for obesity and diabetes; neurological disorders, including migraine; and gastrointestinal disease, including celiac disease. Based in New York City, we are home to some of the world’s most intrepid scientific minds from the world’s top institutions, working alongside a seasoned team with a proven track record of success in drug discovery and development. Together, we are leveraging multiple sophisticated technologies and internally-developed capabilities to bring fundamentally new solutions to some of the most pressing unmet needs in human health.

Company Details

Employees
70
Address
430 E. 29th Street, New York,new York 10016,united States
Email
in****@****ope.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
New York, New York
Looking for a particular Kallyope employee's phone or email?

Kallyope Questions

News

Discovery of Gut-Targeted GPR40 Agonist K-757 and GPR119 Agonist K-833, a Combination Treatment for Metabolic Disorders - ACS Publications

Discovery of Gut-Targeted GPR40 Agonist K-757 and GPR119 Agonist K-833, a Combination Treatment for Metabolic Disorders ACS Publications

Kallyope seems to shift gears to focus on neuro after disappointing weight loss data - FirstWord Pharma

Kallyope seems to shift gears to focus on neuro after disappointing weight loss data FirstWord Pharma

Kallyope Discreetly Drops Disappointing Data for Oral Obesity Candidate - BioSpace

Kallyope Discreetly Drops Disappointing Data for Oral Obesity Candidate BioSpace

Kallyope quietly reports Phase 2 obesity data, begins mid-stage migraine trial - Endpoints News

Kallyope quietly reports Phase 2 obesity data, begins mid-stage migraine trial Endpoints News

Kallyope links oral obesity combo to 3% weight loss, rejigs pipeline as migraine asset advances - Fierce Biotech

Kallyope links oral obesity combo to 3% weight loss, rejigs pipeline as migraine asset advances Fierce Biotech

Kallyope Appoints Franz Humer, Ph.D., as Chair of its Board of Directors - Business Wire

Kallyope Appoints Franz Humer, Ph.D., as Chair of its Board of Directors Business Wire

Kallyope Inc. Launches With $44M Series A Financing To Harness The Potential Of The Gut-Brain Axis - PR Newswire

Kallyope Inc. Launches With $44M Series A Financing To Harness The Potential Of The Gut-Brain Axis PR Newswire

Kallyope Appoints Patrick Flanigan as Chief Financial Officer - citybiz

Kallyope Appoints Patrick Flanigan as Chief Financial Officer citybiz

Kallyope to expand its metabolic disorder programme globally - Clinical Trials Arena

Kallyope to expand its metabolic disorder programme globally Clinical Trials Arena

Kallyope Is Digesting Gut–Brain Biology into Medicines - Mary Ann Liebert, Inc.

Kallyope Is Digesting Gut–Brain Biology into Medicines Mary Ann Liebert, Inc.

Biotech execs vie for a share of obesity drug boom: ‘It’s the early innings’ - statnews.com

Biotech execs vie for a share of obesity drug boom: ‘It’s the early innings’ statnews.com

Kallyope’s focus on the gut-brain axis yields a diverse portfolio - drugdiscoverytrends.com

Kallyope’s focus on the gut-brain axis yields a diverse portfolio drugdiscoverytrends.com

PIII/PV=O Catalyzed Cascade Synthesis of N‐Functionalized Azaheterocycles - Wiley Online Library

PIII/PV=O Catalyzed Cascade Synthesis of N‐Functionalized Azaheterocycles Wiley Online Library

A startup that wants to better understand the relationship our gut has to our brain just raised $66 million - businessinsider.com

A startup that wants to better understand the relationship our gut has to our brain just raised $66 million businessinsider.com

Investors Go with Their Gut, Dropping $236M into Kallyope - BioSpace

Investors Go with Their Gut, Dropping $236M into Kallyope BioSpace

Kallyope, with ex-Merck exec at helm, skirts 'less desirable' public markets with $236M series D - Fierce Biotech

Kallyope, with ex-Merck exec at helm, skirts 'less desirable' public markets with $236M series D Fierce Biotech

Biotech startup will mine the gut for drugs affecting human behavior - statnews.com

Biotech startup will mine the gut for drugs affecting human behavior statnews.com

Former Merck exec joins Kallyope as president, soon-to-be CEO - Fierce Biotech

Former Merck exec joins Kallyope as president, soon-to-be CEO Fierce Biotech

Addressing the Obesity Epidemic: The Need for New Oral Agents - BioSpace

Addressing the Obesity Epidemic: The Need for New Oral Agents BioSpace

Kallyope carries series B round to $87m - - Global Venturing

Kallyope carries series B round to $87m - Global Venturing

Kallyope discovers GPR119 agonists for metabolic and nutrition disorders - BioWorld MedTech

Kallyope discovers GPR119 agonists for metabolic and nutrition disorders BioWorld MedTech

New York City gut-brain biotech backed by Bill Gates raises $112 million - The Business Journals

New York City gut-brain biotech backed by Bill Gates raises $112 million The Business Journals

MindMaze, Kallyope Land Big Rounds As Neurotherapeutics Continues To Sizzle - Crunchbase News

MindMaze, Kallyope Land Big Rounds As Neurotherapeutics Continues To Sizzle Crunchbase News

Kallyope Raises Another $112M to Map Out the Gut-Brain Axis to Develop Therapies to Combat Obesity - AlleyWatch

Kallyope Raises Another $112M to Map Out the Gut-Brain Axis to Develop Therapies to Combat Obesity AlleyWatch

Notable Women in Healthcare 2019: Nancy Thornberry - Crain's New York Business

Notable Women in Healthcare 2019: Nancy Thornberry Crain's New York Business

Top Kallyope Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant